Cointime

Royal Emerald Pharmaceuticals

company

About

Royal Emerald Pharmaceuticals produces non-addictive alternate medicines for dilemmas of PTSD and other health consequences.

  • 251 - 500

Highlights

Total Funding Amount
$16.97M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Debt Financing
Last Funding Money Raised
$16.97M
Industries
Alternative Medicine,Health Care,Pharmaceutical
Founded date
Jan 1, 2017
Number Of Employee
251 - 500
Operating Status
Active

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$16.97M
Royal Emerald Pharmaceuticals has raised a total of $16.97M in funding over 2 rounds. Their latest funding was raised on Mar 8, 2022 from a Debt Financing round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 8, 2022 Debt Financing $16.97M 1 Pelorus Equity Group — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Royal Emerald Pharmaceuticals is funded by 1 investors. Pelorus Equity Group are the most recent investors.
Investor Name Lead Investor Funding Round
Pelorus Equity Group Yes Debt Financing
Cointime
เนื้อหา
บริษัท